Bioengineering assistant professor Girgis Obaid at the University of Texas at Dallas and cancer researcher Rolf Brekken at UT ...

Advancements in prostate cancer screening may be contributing to more reported cases, but are men being overdiagnosed?

Radiomics, the extraction of quantitative features from medical images, combined with AI, showed high accuracy in predicting ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, today announced the launch of Sentinel ...

When it comes to antioxidants, blueberries aren't the only game in town. Here are alternatives that pack a stronger ...

“The AI test has a negligible failure rate, while current genomic tests have a failure rate of 20% to 30%, necessitating ...

Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Thanks to artificial intelligence (AI), more women might soon benefit from targeted breast cancer treatment, a new study says ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...